Protalix BioTherapeutics, Inc. (DE) financial statements, including revenue, expenses, profit, and loss
The total revenue of PLX for the last quarter is 10.49 M USD, and it's 1.36% higher compared to the previous quarter. The net income of Q4 23 is -6.04 M USD.